• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢综合征与癌症:从床边到实验室再回归临床

Metabolic syndrome and cancer: from bedside to bench and back.

作者信息

Extermann Martine

机构信息

Senior Adult Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL 33612, USA.

出版信息

Interdiscip Top Gerontol. 2013;38:49-60. doi: 10.1159/000343621. Epub 2013 Jan 17.

DOI:10.1159/000343621
PMID:23503515
Abstract

As older patients present with an average of three comorbidities beside their cancer, geriatric oncology can provide unique clues to translational research in aging and cancer. We illustrate this approach with the example of the metabolic syndrome and cancer. Epidemiologic and clinical cohorts highlighted an association between the metabolic syndrome and a higher risk and worse prognosis of various cancers. In a bedside-to-bench transition, this led to an interest in analyzing the potential mechanisms underlying this association. At least ten potential mechanisms could be implicated, with the challenge of understanding which are the dominant ones in human patients. Bench-to-bedside studies are beginning to shed some light on that aspect, and some therapeutic trials are beginning to exploit the lessons learned.

摘要

由于老年患者除患癌症外平均还患有三种合并症,老年肿瘤学可为衰老与癌症的转化研究提供独特线索。我们以代谢综合征与癌症为例来说明这种方法。流行病学和临床队列研究突出了代谢综合征与多种癌症的较高风险及较差预后之间的关联。在从床边到实验室的转化过程中,这引发了人们对分析这种关联背后潜在机制的兴趣。可能涉及至少十种潜在机制,而难点在于了解哪些是人类患者中的主要机制。从实验室到床边的研究已开始在这方面有所启发,一些治疗试验也已开始借鉴所学到的经验。

相似文献

1
Metabolic syndrome and cancer: from bedside to bench and back.代谢综合征与癌症:从床边到实验室再回归临床
Interdiscip Top Gerontol. 2013;38:49-60. doi: 10.1159/000343621. Epub 2013 Jan 17.
2
[The metabolic syndrome and type-2 diabetes mellitus as conditions predisposing for malignant tumors].代谢综合征和2型糖尿病作为恶性肿瘤的易感因素
Orv Hetil. 2008 Dec 21;149(51):2403-11. doi: 10.1556/OH.2008.28507.
3
Contribution of RAGE axis activation to the association between metabolic syndrome and cancer.AGE 轴激活在代谢综合征与癌症之间的关联中的作用。
Mol Cell Biochem. 2021 Mar;476(3):1555-1573. doi: 10.1007/s11010-020-04022-z. Epub 2021 Jan 4.
4
Targeting peroxisome proliferator-activated receptors (PPARs): development of modulators.靶向过氧化物酶体增殖物激活受体(PPARs):调节剂的研发
J Med Chem. 2012 May 10;55(9):4027-61. doi: 10.1021/jm101360s. Epub 2012 Feb 27.
5
PPARs as targets for the modulation of cardiovascular risk factors associated with the metabolic syndrome.过氧化物酶体增殖物激活受体作为调节与代谢综合征相关的心血管危险因素的靶点。
Curr Opin Investig Drugs. 2004 Sep;5(9):936-40.
6
Visceral obesity, metabolic syndrome, insulin resistance and cancer.内脏型肥胖、代谢综合征、胰岛素抵抗与癌症。
Proc Nutr Soc. 2012 Feb;71(1):181-9. doi: 10.1017/S002966511100320X. Epub 2011 Nov 3.
7
Dietary modulators of peroxisome proliferator-activated receptors: implications for the prevention and treatment of metabolic syndrome.过氧化物酶体增殖物激活受体的饮食调节剂:对代谢综合征预防和治疗的意义
J Nutrigenet Nutrigenomics. 2008;1(3):126-35. doi: 10.1159/000112460. Epub 2008 Feb 20.
8
Insulin and cancer.胰岛素与癌症
Integr Cancer Ther. 2003 Dec;2(4):315-29. doi: 10.1177/1534735403259152.
9
Targeting components of the stress system as potential therapies for the metabolic syndrome: the peroxisome-proliferator-activated receptors.将应激系统的组成部分作为代谢综合征的潜在治疗靶点:过氧化物酶体增殖物激活受体
Ann N Y Acad Sci. 2006 Nov;1083:306-18. doi: 10.1196/annals.1367.019.
10
Peroxisome proliferator-activated receptor gamma: its role in metabolic syndrome.过氧化物酶体增殖物激活受体γ:其在代谢综合征中的作用
Cardiovasc Radiat Med. 2004 Apr-Jun;5(2):97-103. doi: 10.1016/j.carrad.2004.03.006.

引用本文的文献

1
Associations between "Cancer Risk", "Inflammation" and "Metabolic Syndrome": A Scoping Review.“癌症风险”“炎症”与“代谢综合征”之间的关联:一项范围综述
Biology (Basel). 2024 May 16;13(5):352. doi: 10.3390/biology13050352.
2
Dyslipidemia and non-small cell lung cancer risk in Chinese population: a case-control study.血脂异常与中国人群非小细胞肺癌风险的病例对照研究。
Lipids Health Dis. 2018 Dec 6;17(1):278. doi: 10.1186/s12944-018-0925-z.
3
Case-control study of metabolic syndrome and ovarian cancer in Chinese population.中国人群中代谢综合征与卵巢癌的病例对照研究。
Nutr Metab (Lond). 2017 Feb 28;14:21. doi: 10.1186/s12986-017-0176-4. eCollection 2017.
4
The Impact of Immunosenescence on Pulmonary Disease.免疫衰老对肺部疾病的影响。
Mediators Inflamm. 2015;2015:692546. doi: 10.1155/2015/692546. Epub 2015 Jun 23.
5
Weight change therapy as a potential treatment for end-stage ovarian carcinoma.体重变化疗法作为晚期卵巢癌的一种潜在治疗方法。
Am J Case Rep. 2014 May 12;15:203-11. doi: 10.12659/AJCR.890229. eCollection 2014.